Who Holds Actinium Pharmaceuticals, Inc. (ATNM)? 47 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 47 holders, $5 million in total.
Largest holders
The 47 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 1,238,302 | $1 million | -1% | 13F |
| COMPASS FINANCIAL MANAGEMENT LLC | 600,230 | $588,225 | New | 13F |
| MILLENNIUM MANAGEMENT LLC | 514,580 | $504,288 | -9% | 13F |
| BlackRock, Inc. | 395,896 | $387,978 | +7% | 13F |
| RENAISSANCE TECHNOLOGIES LLC | 380,491 | $372,881 | -19% | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 324,945 | $318,553 | -3% | 13F |
| TWO SIGMA INVESTMENTS, LP | 259,179 | $253,995 | -23% | 13F |
| GAGNON SECURITIES LLC | 182,142 | $178,499 | -10% | 13F |
| VANGUARD FIDUCIARY TRUST CO | 161,526 | $158,295 | +1% | 13F |
| STATE STREET CORP | 122,215 | $119,771 | -3% | 13F |
| Gen-Wealth Partners Inc | 105,111 | $103,009 | -2% | 13F |
| NORTHERN TRUST CORP | 69,743 | $68,348 | -8% | 13F |
| Qube Research & Technologies Ltd | 57,812 | $56,656 | +220% | 13F |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 56,822 | $55,685 | -54% | 13F |
| Vontobel Holding Ltd. | 50,000 | $49,000 | +67% | 13F |
| Bluespring Wealth Management, LLC | 43,000 | $42,140 | New | 13F |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 40,000 | $39,200 | +0% | 13F |
| Gerald Baker Financial Group LLC | 22,691 | $22,237 | +0% | 13F |
| MAYPORT, LLC | 22,000 | $21,560 | +0% | 13F |
| NORTH STAR ASSET MANAGEMENT INC | 20,000 | $19,600 | +0% | 13F |
| WELLS FARGO & COMPANY/MN | 19,800 | $19,404 | +0% | 13F |
| OSAIC HOLDINGS, INC. | 18,865 | $18,487 | -5% | 13F |
| XTX Topco Ltd | 13,731 | $13,456 | -55% | 13F |
| Savvy Advisors, Inc. | 10,000 | $9,800 | +0% | 13F |
| Vanguard Global Advisers, LLC | 8,893 | $8,715 | +0% | 13F |
| UBS Group AG | 6,758 | $6,623 | -54% | 13F |
| MORGAN STANLEY | 6,341 | $6,214 | -53% | 13F |
| Rockefeller Capital Management L.P. | 4,000 | $3,920 | +0% | 13F |
| Steward Partners Investment Advisory, LLC | 2,000 | $1,960 | -8% | 13F |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 1,657 | $1,624 | +1449% | 13F |
| JPMORGAN CHASE & CO | 1,494 | $1,479 | +0% | 13F |
| JONES FINANCIAL COMPANIES LLLP | 1,351 | $1,337 | +285% | 13F |
| NATIONAL BANK OF CANADA /FI/ | 921 | $903 | -10% | 13F |
| ACADIAN ASSET MANAGEMENT LLC | 496,288 | $485 | -17% | 13F |
| SBI Securities Co., Ltd. | 492 | $482 | -9% | 13F |
| PITTENGER & ANDERSON INC | 341 | $335 | +0% | 13F |
| HARBOUR INVESTMENTS, INC. | 334 | $327 | New | 13F |
| NISA INVESTMENT ADVISORS, LLC | 330 | $323 | +0% | 13F |
| Investors Research Corp | 300 | $294 | +0% | 13F |
| Allied Private Wealth LLC | 240 | $232 | New | 13F |
| BARCLAYS PLC | 203 | $199 | New | 13F |
| BNP PARIBAS FINANCIAL MARKETS | 201 | $197 | -15% | 13F |
| FEDERATED HERMES, INC. | 137 | $134 | -90% | 13F |
| AM INVESTMENT STRATEGIES LLC | 29,356 | $29 | +0% | 13F |
| Axiom Investment Management LLC | 5 | $5 | New | 13F |
| Caitong International Asset Management Co., Ltd | 1 | $1 | +0% | 13F |
| ROYAL BANK OF CANADA | 45 | $0 | +0% | 13F |
Questions and answers
- How many institutions hold Actinium Pharmaceuticals, Inc.?
- 47 managers reported Actinium Pharmaceuticals, Inc. on Form 13F for the quarter ended 30 June 2026, against 54 the quarter before.
- Who is the largest institutional holder of Actinium Pharmaceuticals, Inc.?
- VANGUARD CAPITAL MANAGEMENT LLC, with 1,238,302 shares worth $1 million on its 13F for Q2 2026.
- How many institutions bought or sold out of Actinium Pharmaceuticals, Inc. in Q2 2026?
- 6 managers reported a new position and 13 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Actinium Pharmaceuticals, Inc., Q2 2026", https://app.tamarly.ai/holders/actinium-pharmaceuticals, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.